Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Jones

Showing results (631-640 of 3,665) with videos related to

Pageof 367
Sort By:
Diagnostic Microbiology and Infectious Disease|September 1, 1989
Detection of staphylococcal resistance to penicillinase-resistant penicillins. A comparison of two widely used disk diffusion methodsR N Jones, A L Barry
Diagnostic Microbiology and Infectious Disease|April 29, 1998
Timed kill kinetic studies of levofloxacin, ofloxacin, and ciprofloxacin against Moraxella catarrhalisM S Barrett, R N Jones
American Journal of Clinical Pathology|October 1, 1982
Interlaboratory performance of disk agar diffusion and dilution antimicrobial susceptibility tests, 1979-1981. A summary of the microbiology portion of the College of American Pathologists (CAP) surveysR N Jones, D C Edson
The Journal of Antimicrobial Chemotherapy|April 1, 1989
In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agentsA L Barry, R N Jones
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
Review of common therapeutic options in the United States for the treatment of pediculosis capitisKimberly N Jones, Joseph C English
Diagnostic Microbiology and Infectious Disease|July 18, 2003
Antagonism between penicillin and erythromycin against Streptococcus pneumoniae: does it exist?Lalitagauri M Deshpande, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|May 6, 2003
Comparative activity of garenoxacin (BMS 284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999-2001)Ronald N Jones, Douglas J Biedenbach
Diagnostic Microbiology and Infectious Disease|May 14, 2003
Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance programDouglas J Biedenbach, Ronald N Jones
Biochemical and Biophysical Research Communications|February 26, 1982
Cytotoxic effects of butyrate and other 'differentiation inducers' on immature lymphoid cellsP A Bell, C N Jones
Diagnostic Microbiology and Infectious Disease|June 1, 1983
Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testingR N Jones, A L Barry
Pageof 367

Showing results (631-640 of 3,665) with videos related to

Sort By:
Pageof 367
Diagnostic Microbiology and Infectious Disease|September 1, 1989
Detection of staphylococcal resistance to penicillinase-resistant penicillins. A comparison of two widely used disk diffusion methodsR N Jones, A L Barry
Diagnostic Microbiology and Infectious Disease|April 29, 1998
Timed kill kinetic studies of levofloxacin, ofloxacin, and ciprofloxacin against Moraxella catarrhalisM S Barrett, R N Jones
American Journal of Clinical Pathology|October 1, 1982
Interlaboratory performance of disk agar diffusion and dilution antimicrobial susceptibility tests, 1979-1981. A summary of the microbiology portion of the College of American Pathologists (CAP) surveysR N Jones, D C Edson
The Journal of Antimicrobial Chemotherapy|April 1, 1989
In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agentsA L Barry, R N Jones
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
Review of common therapeutic options in the United States for the treatment of pediculosis capitisKimberly N Jones, Joseph C English
Diagnostic Microbiology and Infectious Disease|July 18, 2003
Antagonism between penicillin and erythromycin against Streptococcus pneumoniae: does it exist?Lalitagauri M Deshpande, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|May 6, 2003
Comparative activity of garenoxacin (BMS 284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999-2001)Ronald N Jones, Douglas J Biedenbach
Diagnostic Microbiology and Infectious Disease|May 14, 2003
Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance programDouglas J Biedenbach, Ronald N Jones
Biochemical and Biophysical Research Communications|February 26, 1982
Cytotoxic effects of butyrate and other 'differentiation inducers' on immature lymphoid cellsP A Bell, C N Jones
Diagnostic Microbiology and Infectious Disease|June 1, 1983
Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testingR N Jones, A L Barry
Pageof 367